Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation

被引:47
作者
Bruchfeld, Annette [1 ]
Carrero, Juan J. [2 ]
Qureshi, Abdul R. [2 ]
Lindholm, Bengt [2 ]
Barany, Peter
Heimburger, Olof
Hu, Maowen [3 ]
Lin, Xinchun [3 ]
Stenvinkel, Peter
Miller, Edmund J. [3 ,4 ]
机构
[1] Karolinska Univ Hosp Huddinge, Div Renal Med, Dept Clin Sci Intervent & Technol, Karolinska Inst,CLINTEC, S-14186 Huddinge, Sweden
[2] Karolinska Inst, CLINTEC, Baxter Novum, Stockholm, Sweden
[3] Feinstein Inst Med Res, Manhasset, NY USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
基金
英国医学研究理事会;
关键词
HUMAN ATHEROSCLEROTIC PLAQUES; CHRONIC-RENAL-FAILURE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; TNF-ALPHA; INTERLEUKIN-6; MALNUTRITION; INFLAMMATION; EXPRESSION; MORTALITY;
D O I
10.2119/molmed.2008.00109
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chronic kidney disease (CKD) carries an increased risk of cardiovascular disease (CVD). Macrophage migration inhibiting factor (MIF) is a proinflammatory cytokine implicated in the pathogenesis of sepsis, autoimmune disease, atherogenesis, and plaque instability, and is a known cardiac depressant. This post-hoc, cross-sectional study examined whether MIF serum concentrations are elevated in CKD patients. Our study included CKD 3-5 patients with moderate to severe renal dysfunction (n = 257) (mean age SD; 55 +/- 12 years) and 53 controls (60 +/- 12 years). Serum MIF concentrations, measured by enzyme-linked immunosorbent assay (ELISA), were studied in relation to glomerular filtration rate (GFR), presence of CVD, outcome and inflammatory and oxidative stress markers. MIF was significantly elevated in CKD patients compared with controls (CKD: median 676 (range 118-8275 pg/mL) controls: 433 (142-4707) pg/mL: P = 0.008). MIF was also associated with 8-hydroxy-2-deoxyguanosine (8-OH-dG) levels (rho = 0.26: P = 0.001), a marker of oxidative stress, and ICAM-1 levels (rho = 0.14, P = 0.02), a marker of endothelial activation. However, the elevated MIF concentrations were neither correlated with glomerular filtration rate (GFR) nor inflammatory markers such as CRP. IL-6, and TNF. When combining MIF and IL-6 as a marker of inflammation, a significant increase in risk for CVD was found, but when analyzing all-cause mortality, this did not differ significantly with regard to mortality from inflamed patients with low MIF levels. The data suggest that increased serum MIF levels found in CKD is not caused primarily by poor renal function, but is associated with markers of oxidative stress and endothelial activation and may play a role in vascular disease associated with CKD. (C) 2009 The Feinstein Institute for Medical Research, www.feinsteininstitute.org Online address: http://www.molmed.org doi: 10.2119/molmed.2008.00109
引用
收藏
页码:70 / 75
页数:6
相关论文
共 26 条
  • [1] Inflammation and wasting in chronic kidney disease: Partners in crime
    Avesani, C. M.
    Carrero, J. J.
    Axelsson, J.
    Qureshi, A. R.
    Lindholm, B.
    Stenvinkel, P.
    [J]. KIDNEY INTERNATIONAL, 2006, 70 : S8 - S13
  • [2] BECKER H, 2006, CLIN RHEUMATOL, V4, P1
  • [3] Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection
    Brown, FG
    Nikolic-Paterson, DJ
    Chadban, SJ
    Dowling, J
    Jose, M
    Metz, CN
    Bucala, R
    Atkins, RC
    [J]. TRANSPLANTATION, 2001, 71 (12) : 1777 - 1783
  • [4] High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
    Bruchfeld, Annette
    Qureshi, Abdul Rashid
    Lindholm, Bengt
    Barany, Peter
    Yang, LiHong
    Stenvinkel, Peter
    Tracey, Kevin J.
    [J]. MOLECULAR MEDICINE, 2008, 14 (3-4) : 109 - 115
  • [5] Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF)
    Burger-Kentischer, A
    Göbel, H
    Kleemann, R
    Zerneckee, A
    Bucala, R
    Leng, L
    Finkelmeier, D
    Geiger, G
    Schaefer, HE
    Schober, A
    Weber, C
    Brunner, H
    Rütten, H
    Ihling, C
    Bernhagen, J
    [J]. ATHEROSCLEROSIS, 2006, 184 (01) : 28 - 38
  • [7] DESCAMPSLATSCHA B, 1995, J IMMUNOL, V154, P882
  • [8] Clinical epidemiology of cardiovascular disease in chronic renal disease
    Foley, RN
    Parfrey, PS
    Sarnak, MJ
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) : S112 - S119
  • [9] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
    Go, AS
    Chertow, GM
    Fan, DJ
    McCulloch, CE
    Hsu, CY
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) : 1296 - 1305
  • [10] Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
    Honda, H
    Qureshi, AR
    Heimbürger, O
    Barany, P
    Wang, K
    Pecoits-Filho, R
    Stenvinkel, P
    Lindholm, B
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) : 139 - 148